Level Biotechnology Inc. (TPEX:3118)
Taiwan
· Delayed Price · Currency is TWD 33.75
+0.20 (0.60%)
Apr 29, 2026, 1:21 PM CST
Level Biotechnology Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 210.34 | 252.78 | 467.41 | 463.5 | 472.96 | Upgrade
|
| Cash & Short-Term Investments | 210.34 | 252.78 | 467.41 | 463.5 | 472.96 | Upgrade
|
| Cash Growth | -16.79% | -45.92% | 0.84% | -2.00% | 24.36% | Upgrade
|
| Accounts Receivable | 158.85 | 113.79 | 110.35 | 118.39 | 96.15 | Upgrade
|
| Other Receivables | 4.66 | 3.19 | 2.47 | 2.27 | 2.37 | Upgrade
|
| Receivables | 163.51 | 116.98 | 112.82 | 120.66 | 98.52 | Upgrade
|
| Inventory | 115.61 | 98.09 | 88.85 | 73.7 | 56.17 | Upgrade
|
| Prepaid Expenses | - | - | 11.39 | 7.95 | 6.58 | Upgrade
|
| Other Current Assets | 10.5 | 16.1 | 0.03 | 0.01 | 0.02 | Upgrade
|
| Total Current Assets | 499.95 | 483.95 | 680.5 | 665.82 | 634.24 | Upgrade
|
| Property, Plant & Equipment | 323.52 | 313.11 | 105.81 | 113.01 | 122.41 | Upgrade
|
| Long-Term Investments | 8.22 | - | - | - | - | Upgrade
|
| Other Intangible Assets | - | - | - | 0.02 | 0.05 | Upgrade
|
| Other Long-Term Assets | 35.12 | 30.05 | 36.36 | 33.68 | 30.92 | Upgrade
|
| Total Assets | 866.8 | 827.11 | 822.67 | 812.53 | 787.62 | Upgrade
|
| Accounts Payable | 67.7 | 52.93 | 50.47 | 65.34 | 48.01 | Upgrade
|
| Accrued Expenses | 31.05 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 4.27 | 4.7 | 3.53 | 2.77 | 2.22 | Upgrade
|
| Current Income Taxes Payable | 9.67 | 8.4 | 8.35 | 6.35 | 9.56 | Upgrade
|
| Current Unearned Revenue | 154.16 | 153.23 | 154.34 | 151.13 | 128.11 | Upgrade
|
| Other Current Liabilities | 7.83 | 33.22 | 36.08 | 29 | 37.27 | Upgrade
|
| Total Current Liabilities | 274.68 | 252.49 | 252.76 | 254.59 | 225.17 | Upgrade
|
| Long-Term Leases | 3.71 | 7.98 | 9.89 | 9.8 | 10.96 | Upgrade
|
| Pension & Post-Retirement Benefits | 7.99 | 6.48 | 7.43 | 5.49 | 6.4 | Upgrade
|
| Other Long-Term Liabilities | 0.25 | 0.25 | 3.13 | 0.25 | 0.25 | Upgrade
|
| Total Liabilities | 286.63 | 267.19 | 273.2 | 270.13 | 242.78 | Upgrade
|
| Common Stock | 324.53 | 324.53 | 324.53 | 324.53 | 324.53 | Upgrade
|
| Additional Paid-In Capital | 56.05 | 56.05 | 56.05 | 56.05 | 56.05 | Upgrade
|
| Retained Earnings | 199.6 | 179.34 | 168.9 | 161.83 | 164.27 | Upgrade
|
| Shareholders' Equity | 580.18 | 559.91 | 549.47 | 542.4 | 544.84 | Upgrade
|
| Total Liabilities & Equity | 866.8 | 827.11 | 822.67 | 812.53 | 787.62 | Upgrade
|
| Total Debt | 7.98 | 12.68 | 13.41 | 12.57 | 13.18 | Upgrade
|
| Net Cash (Debt) | 202.36 | 240.1 | 453.99 | 450.92 | 459.78 | Upgrade
|
| Net Cash Growth | -15.72% | -47.11% | 0.68% | -1.93% | 26.15% | Upgrade
|
| Net Cash Per Share | 6.19 | 7.35 | 13.90 | 13.80 | 14.08 | Upgrade
|
| Filing Date Shares Outstanding | 32.45 | 32.45 | 32.45 | 32.45 | 32.45 | Upgrade
|
| Total Common Shares Outstanding | 32.45 | 32.45 | 32.45 | 32.45 | 32.45 | Upgrade
|
| Working Capital | 225.26 | 231.46 | 427.74 | 411.22 | 409.06 | Upgrade
|
| Book Value Per Share | 17.88 | 17.25 | 16.93 | 16.71 | 16.79 | Upgrade
|
| Tangible Book Value | 580.18 | 559.91 | 549.47 | 542.38 | 544.8 | Upgrade
|
| Tangible Book Value Per Share | 17.88 | 17.25 | 16.93 | 16.71 | 16.79 | Upgrade
|
| Land | 128.12 | 128.12 | 15.61 | 15.61 | 15.61 | Upgrade
|
| Buildings | 341.47 | 320.29 | 211.76 | 211.76 | 210.42 | Upgrade
|
| Machinery | 107.93 | 99.32 | 110.05 | 111.09 | 106.89 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.